Adipose tissue stem cells: the great WAT hope
Trends in Endocrinology & Metabolism, 2012•cell.com
The past decade has witnessed an explosion in research into adipose tissue stem cells
(ASCs), facilitated by their ease of isolation from white adipose tissue (WAT) and fueled by
their therapeutic potential. Recent developments have extended ASC multipotency to
include endodermal and ectodermal cell types, as well as the generation of induced
pluripotent stem cells. This expanding multipotency has been paralleled by burgeoning
translational applications, ranging from tissue engineering to anti-cancer therapy, that are …
(ASCs), facilitated by their ease of isolation from white adipose tissue (WAT) and fueled by
their therapeutic potential. Recent developments have extended ASC multipotency to
include endodermal and ectodermal cell types, as well as the generation of induced
pluripotent stem cells. This expanding multipotency has been paralleled by burgeoning
translational applications, ranging from tissue engineering to anti-cancer therapy, that are …
The past decade has witnessed an explosion in research into adipose tissue stem cells (ASCs), facilitated by their ease of isolation from white adipose tissue (WAT) and fueled by their therapeutic potential. Recent developments have extended ASC multipotency to include endodermal and ectodermal cell types, as well as the generation of induced pluripotent stem cells. This expanding multipotency has been paralleled by burgeoning translational applications, ranging from tissue engineering to anti-cancer therapy, that are currently subject to clinical trials. However, this promise is tempered by potential pitfalls, such as tumorigenicity, and is further undermined by lingering uncertainties regarding the precise identity of ASCs. Confronting these issues will be essential if we are to bypass the pitfalls and develop the promises of ASCs.
cell.com
以上显示的是最相近的搜索结果。 查看全部搜索结果